致编辑的信：使用直接抗病毒药物连续治疗超过12个月后成功治愈耐多药丙型肝炎 - Suppr | 超能文献

Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals.

作者信息

Trudeau Sheri, Mendiratta Vivek, Dababneh Yara, Hollingsworth Jennifer, Gordon Stuart C

机构信息

Department of Public Health Sciences , Henry Ford Health , Detroit , Michigan , USA.

Department of Gastroenterology and Hepatology , Henry Ford Health , Detroit , Michigan , USA.

出版信息

Hepatology. 2023 Jan 1;77(1):E9-E10. doi: 10.1002/hep.32688. Epub 2022 Aug 10.

DOI:10.1002/hep.32688

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals.致编辑的信：使用直接抗病毒药物连续治疗超过12个月后成功治愈耐多药丙型肝炎

Hepatology. 2023 Jan 1;77(1):E9-E10. doi: 10.1002/hep.32688. Epub 2022 Aug 10.

2

Letter to the editor: Successful treatment of multidrug-resistant hepatis C after >12 months of continuous therapy with direct-acting antivirals.致编辑的信：使用直接抗病毒药物连续治疗超过12个月后成功治愈耐多药丙型肝炎

Hepatology. 2023 Feb 1;77(2):E26-E27. doi: 10.1002/hep.32706. Epub 2022 Aug 28.

3

Letter to the editor: Oral antivirals in treatment-naïve chronic hepatitis C infection.致编辑的信：初治慢性丙型肝炎感染中的口服抗病毒药物

Hepatology. 2022 May;75(5):1339. doi: 10.1002/hep.32311. Epub 2022 Jan 12.

4

Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals.通过直接作用抗病毒药物实现持续病毒学应答的慢性丙型肝炎患者中脂蛋白（a）的定量变化

Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):102011. doi: 10.1016/j.clinre.2022.102011. Epub 2022 Aug 27.

5

Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event.

Clin Res Hepatol Gastroenterol. 2022 Dec;46(10):102042. doi: 10.1016/j.clinre.2022.102042. Epub 2022 Oct 22.

6

Hepatitis C virus viral load distribution in the era of extended access to direct acting antivirals treatment: a real-life single center study.直接作用抗病毒药物广泛应用时代的丙型肝炎病毒载量分布：一项真实世界单中心研究

Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e1076-e1077. doi: 10.1097/MEG.0000000000002088.

7

Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action.撒哈拉以南非洲地区对直接作用抗病毒药物的耐药性是否会对丙型肝炎病毒的消除构成威胁？行动建议。

J Hepatol. 2020 Mar;72(3):583-584. doi: 10.1016/j.jhep.2019.10.017. Epub 2019 Dec 10.

8

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study.尽管艾滋病毒和丙型肝炎病毒感染者可不受限制地获得直接抗病毒治疗，但仍未开始治疗的原因：一项跨国前瞻性队列研究。

Lancet Public Health. 2023 Apr;8(4):e294-e304. doi: 10.1016/S2468-2667(23)00056-7.

9

Direct-acting Antivirals for Hepatitis C and Implication for Community Pharmacy Practice.直接作用抗病毒药物治疗丙型肝炎及其对社区药学实践的影响。

Curr Pharm Des. 2023;29(25):1967-1970. doi: 10.2174/1381612829666230816145931.

10

Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C.为注射毒品感染丙型肝炎的人创造公平获得直接抗病毒治疗的环境。

Liver Int. 2020 Oct;40(10):2353-2355. doi: 10.1111/liv.14661.

引用本文的文献

1

Direct-Acting Antiviral Treatment Failure and Retreatment Strategies Following Hepatitis C-Positive Solid Organ Transplantation in Hepatitis C-Negative Recipients: A Multicenter Case Series.丙型肝炎阴性受者中丙型肝炎阳性实体器官移植后直接抗病毒治疗失败及再治疗策略：一项多中心病例系列研究

Transpl Infect Dis. 2025 Mar 24;27(3):e70024. doi: 10.1111/tid.70024.